Markets week ahead: Brace for volatile sessions

The scare of a global economic slowdown following the outbreak of Coronavirus saw world markets take a severe knock, and Indian equities were not spared.

In the coming week, stocks could continue to trade with extreme volatility in the week ahead, after this week’s biggest one-day loss since 1987 was followed by the best one-day gain since the financial crisis.
Now that stocks have entered a bear market, more wild volatility is expected in the week ahead as investors await decision by central bank around the globe to pump-prime the economy.
In the past week, the market was sharply lower but swung wildly in both directions, including the stunning 10% decline in the Sensed and Nifty on Friday-the worst one-day drop since the 1987 market crash – only to climb back in to positive zone.

Experts believe that the market is closer to finding a bottom, but that will depend on a slowdown in negative news on the virus.

The Nifty is expected to make efforts to gain some stability and attempt a technical rebound. The 9,900 and 10,040 levels will act as key resistance, while supports will come in at 9,500 and 9,300 levels.
The Federal Reserve meets in the coming week, and the market is looking for it to make a big move.

Meanwhile, US President Donald Trump declared a state of emergency Friday, which allows him to tap federal agencies to provide emergency funds and other responses to the crisis.
The president also announced the government would buy oil to fill the Strategic Petroleum Reserves and that 1.4 million test kits would be available in the next week.

Disclaimer –
This document is meant for the recipient only for use as intended and not for circulation. This document should not be reproduced or copied or made available to others. The information contained herein is from the public domain or sources believed to be reliable. While reasonable care has been taken to ensure that information given is at the time believed to be fair and correct and opinions based thereupon are reasonable, due to the very nature of research it cannot be warranted or represented that it is accurate or complete and it should not be relied upon as such. Also above note is not a recommendation to Buy or SELL and is only a view based on facts and figures and we will be in no way responsible for any losses incurred by anyone who uses this information to either trade or invests securities mentioned herein.